Abrdn Healthcare Investors

NYSE:HQH Stock Report

Market Cap: US$817.6m

Abrdn Healthcare Investors Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure17.8yrs

Recent management updates

Recent updates

HQH: Healthcare Fund With 11% Income And A High Discount

Mar 03

HQH: Disappointing Track Record

Feb 04

HQH: I Am Getting A 9.5% Yield On My Last Buy

Dec 19

HQH: New Name But Same Risky Bets On Biotech

Nov 14

HQH: Deep Discount Presents An Opportunity

Jul 03

Tekla Healthcare Investors raises dividend by 7.7% to $0.42

Feb 15

HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering

Dec 24

Equity CEFs: What's Going On With Tekla's HQH And HQL?

Dec 08

Tekla Healthcare Investors declines quarterly dividend by -2.5% to $0.39/share

Nov 16

HQH: A Dividend Paymaster That Fails To Register Price Growth

Oct 20

Tekla Healthcare Investors goes ex-dividend tomorrow

Aug 24

Tekla Healthcare: 10% Yielding CEF Trading Below NAV

Jul 17

Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance

Mar 30

Tekla Healthcare Investors: Understanding The Mechanics Of Its 8.5% Yield

Jan 16

Technical Update On HQH: Presenting An Opportunity

Oct 06

HQH: Higher Valuation, But Still Appealing

Jul 31

Where Fundamentals Meet Technicals: HQH (Revisited) - Yield 7.74%

Jul 08

Evaluating CEFs: HQH Provides A Well-Covered Distribution In A Hot Sector

Jun 27

HQH: An Overweight Biotech Fund, Paying 8%+ Distribution

Jan 14

Tekla Healthcare Investors declares $0.05 special dividend

Dec 21

Tekla Healthcare Investors declares $0.48 dividend

Nov 16

HQH: Deep Discount Leads To High Yield

Nov 09

CEO

Abrdn Healthcare Investors has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Michael Bonney
Independent Trustee13.3yrsUS$26.50kno data
Oleg Pohotsky
Chairman and Independent Trustee of H&Q Life Sciences Investors24.3yrsUS$34.50kno data
Uwe Reinhardt
Independent Trustee and Independent Trustee of H&Q Life Sciences Investors36.3yrsUS$23.50kno data
William Reardon
Independent Trustee14.3yrsUS$30.75kno data
Lucinda Stebbins
Independent Trustee and Independent Trustee of HQL18.3yrsUS$28.00kno data
Rakesh Jain
Trustee and Independent Trustee of HQL17.3yrsUS$24.00kno data

17.8yrs

Average Tenure

76.5yo

Average Age

Experienced Board: HQH's board of directors are seasoned and experienced ( 17.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.